SCHEMBL27134415

SCHEMBL27134415

CNc1ccccc1C(=O)Nc1ncc(N=O)s1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 5/20 0.44
▸ NPC1 O15118 4/20 0.44
▸ PKM P14618 3/20 0.44
▸ ALDH1A1 P00352 6/20 0.43
▸ STAT3 P40763 3/20 0.43
▸ KDM4E B2RXH2 3/20 0.43
▸ MEN1 O00255 3/20 0.42
▸ KMT2A Q03164 3/20 0.42
▸ POLB P06746 3/20 0.42
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ NPSR1 Q6W5P4 2/20 0.41
▸ MLNR O43193 1/20 0.41
▸ NR1I2 O75469 1/20 0.41
▸ ABCB11 O95342 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ ADRB2 P07550 1/20 0.41
▸ CHRM2 P08172 1/20 0.41
▸ ADRB1 P08588 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24073682 0.89 ALDH1A1 (0.44) RAB9ANPC1PKMALDH1A1STAT3
SCHEMBL24072387 0.89 KDM4E (0.44) RAB9ANPC1PKMALDH1A1STAT3
SCHEMBL27134412 0.88 CCNE1 (0.44) RAB9ANPC1PKMALDH1A1STAT3
SCHEMBL24072396 0.87 STAT3 (0.44) RAB9ANPC1PKMALDH1A1STAT3
SCHEMBL24072390 0.86 JAK2 (0.47) RAB9ANPC1PKMALDH1A1STAT3
SCHEMBL24073675 0.86 KDM4E (0.43) RAB9ANPC1PKMALDH1A1STAT3
SCHEMBL27134416 0.85 TSHR (0.51) PKMALDH1A1KDM4EMEN1KMT2A
SCHEMBL24073667 0.85 CCNE1 (0.44) RAB9ANPC1PKMALDH1A1STAT3
SCHEMBL24073673 0.85 KDM4E (0.58) RAB9ANPC1PKMALDH1A1KDM4E
SCHEMBL24072309 0.85 MEN1 (0.49) RAB9ANPC1ALDH1A1STAT3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2024-02-29 — — US disclosed
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2024-02-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 RAB9A 3280/4885NPC1 3949/4885PKM 2487/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback